However, a high expression level of SFRP1 was associated with better prognosis in patients with breast carcinoma, esophageal adenocarcinoma, head and neck squamous cell carcinoma, kidney renal clear cell carcinoma, and pancreatic ductal adenocarcinoma (Fig. 3). The gene discussed is SFRP1; the disease is esophageal adenocarcinoma.